About Patrick Ryan

Patrick Ryan has invested in stocks and traded options for more than a decade. He specializes in growth stocks, with a particular focus on those in the technology and entertainment sectors. Patrick began writing for StockNews.com in 2019. His mission is to pinpoint growth stocks trading at attractive prices. This requires a focus on the fundamentals including in-depth qualitative and quantitative analysis. Patrick often abides by a contrarian market strategy as he analyzes investment opportunities with irreverence for conventional logic. This often leads to finding hidden gems with tremendous long term upside potential.


Recent Articles By Patrick Ryan

: TEVA |  News, Ratings, and Charts

Can Teva Pharmaceutical Stock Continue to Rebound in 2021? 

Teva Pharmaceuticals (TEVA) is one of the leading generic drug companies in the world. After a few months of underperformance, the stock has shown strength in recent weeks. Patrick Ryan notes some red flags that investors should be aware of.
: ESNT |  News, Ratings, and Charts

Four Upgraded Stocks to Buy for 2021

The stock market's momentum from last year is continuing into 2021. While the indices are slightly higher, there is remarkable strength in semis, biotechs, and financials. Patrick Ryan highlights four lesser-known stocks that investors should consider: ENST, SWTX, SKY, and UNFI.
: LAZR |  News, Ratings, and Charts

Avoid These Recently Downgraded Stocks: Luminar Technologies, Seres Therapeutics, Sabre Corporation, and Murphy Oil

Our proprietary POWR Ratings systems evaluates stocks on numerous factors. The ratings are updated on a daily basis resulting in upgrades and downgrades. Recently downgraded stocks such as Luminar Technologies (LAZR), Seres Therapeutics (MCRB), Sabre Corporation (SABR), and Murphy Oil (MUR) are moving in the wrong direction and should be avoided.
: TSLA |  News, Ratings, and Charts

3 Electric Vehicle Stocks Outperforming Tesla in 2021  

Tesla (TSLA) has been synonymous with EVs and is the best-performing stock in the sector. However, there are likely to be multiple winners given the magnitude of the trend. Patrick Ryan highlights three to watch: NIU, GM, and BLBD.
: ABT |  News, Ratings, and Charts

5 Top Healthcare Stocks for 2021  

During the Obama administration, healtlhcare stocks were major outperformers. This is likely to continue under a Biden administration. Patrick Ryan identifies the top 5 healthcare stocks for 2021: ABT, ABBV, MDT, ZTS, and ANTM.
: UNP |  News, Ratings, and Charts

5 Top-Notch Industrial Stocks for 2021

Industrial stocks could see strong gains this year as President-elect Biden is expected to emphasize Infrastructure as key priority in his administration. That's why it would be wise to consider industrial stocks such as Union Pacific Corporation (UNP), Honeywell International (HON), Caterpillar (CAT), Waste Management (WM), and Emerson Electric Company (EMR).
: MOS |  News, Ratings, and Charts

Why Mosaic Stock Can Outperform in 2021

After a recent Analyst upgrade, agriculture stock Mosaic (MOS) has received some investor attention, but is it time to Buy? Patrick Ryan evaluates the company's prospects and whether you should consider buying it. Read more for his insights.
: NKE |  News, Ratings, and Charts

5 Top-Rated Consumer Discretionary Stocks for 2021

Consumer discrtionary stocks are likely to be very strong in the second half of the year. Patrick Ryan gives his take on why investors should consider buying Nike (NKE), Starbux (SBUX), Target (TGT), TJX (TJX), and Chipotle Mexican Grill (CMG).
: TGT |  News, Ratings, and Charts

Up Over 50% in the Past Year, Will Target Stock Continue to Rally in 2021?  

Target (TGT) is adding new locations and gaining ground in eCommerce. Its online sales had an acceleration in growth. In-store shopping is likely to move higher as retail traffic to stores increases with the vaccine's implementation.
: KO |  News, Ratings, and Charts

Should You Buy the Dip in Coca-Cola?

In terms of soda, Coca-Cola (KO) is the household name. As customers become more health conscious though, the company has moved into other beverages. It's stock has shown recent weakness. Should you buy on the dip? Read more to find out.
Page generated in 1.187 seconds.